Integrating sports pharmacists into multidisciplinary healthcare teams: optimising athlete health and performance Authors: Kristal Potter, Brandon Welch, Jessica Beal-Stahl, Sean Casey, Michael Swartzon, Eli M Friedman Published: 2026 Athletes face an increasingly complex landscape in managing their health, as they must balance the use of medications and supplements with anti-doping regulations and the risk of banned substances.1 Medication management in athletes may be further complicated by training and competition across varying time zones, climates and altitudes, which can necessitate dose adjustments. Additional considerations include body-composition-related differences in drug absorption, therapy-associated changes in appetite and the diuretic effects of certain medications. These examples highlight some important considerations for optimising pharmacotherapy in athletes managing acute and chronic medical conditions. To address these challenges, sports medicine teams are increasingly exploring the integration of pharmacists into multidisciplinary athlete care. A sports pharmacist is a highly trained clinician specialising at the intersection of pharmacy and athlete care.2 In practice, the sports pharmacist mirrors the role of an ambulatory care pharmacist but functions within a multidisciplinary sports medicine team, applying advanced knowledge of medications, performance and recovery supplements, anti-doping considerations and interpretation of clinically relevant blood biomarkers (eg, iron or vitamin D). Sports pharmacists can work collaboratively with athletes, teams, other athlete support personnel, sporting organisations, national governing bodies and sports medicine clinics. This editorial introduces the role and integration of a sports pharmacist into athlete care. Defining the sports pharmacist beyond anti-doping Sports pharmacy is defined as an emerging subspecialty that applies advanced pharmacy training to the care of athletes and physically active individuals.2 3 Sports pharmacists can support athletes across all levels of participation, from recreational (box 1) and collegiate athletes to elite international competition, reflecting a far broader scope than previously acknowledged.4 Publications describing the integration of sports pharmacists within academic medical centres and health systems illustrate that this role is already being operationalised into practice, though in an ad hoc manner.4,6 Medication optimisation case example A 44-year-old competitive marathon runner was prescribed duloxetine for chronic musculoskeletal pain and comorbid anxiety. He reported worsening fatigue, excessive sweating and unexpected heart-rate elevations during training sessions. A medication review conducted by a sports pharmacist identified concurrent use of a pre-workout supplement containing caffeine and guarana, used to enhance endurance performance. The sports pharmacist recognised the potential for additive sympathomimetic effects from duloxetine and multiple stimulant-containing supplement ingredients, contributing to cardiovascular strain during prolonged aerobic exercise. A targeted assessment was performed to evaluate medication–supplement interactions, stimulant burden and training-related risk. The supplement was reviewed for third-party testing and anti-doping compliance to reduce inadvertent exposure to prohibited substances. In collaboration with the prescribing clinician, the sports pharmacist recommended modifications to duloxetine dosing and timing to better mitigate exercise-related adverse effects and advised transitioning to a lower-caffeine, third-party tested pre-workout alternative. Following these coordinated interventions, the athlete reported improved exercise tolerance, reduced cardiovascular symptoms during training and improved confidence in supplement safety. Pharmacists complete extensive doctoral-level education (Doctor of Pharmacy) followed by optional postgraduate training, such as residencies or fellowships, to specialise in areas such as ambulatory care, emergency medicine, or critical care. Many also pursue additional credentials, including board certifications in pharmacotherapy or other specialty areas. This advanced training equips pharmacists with the clinical expertise necessary to optimise medication regimens, manage supplements and mitigate drug-related risks, all while supporting athletic performance. The role of the pharmacist in athlete care remains undefined in most healthcare frameworks. Existing definitions, such as those from the International Pharmaceutical Federation and the Japan Anti-Doping Agency, often confine the role of sports pharmacists to anti-doping support and advising elite athletes within the World Anti-Doping Agency framework.7 8 Current literature of sports pharmacy practice also highlights the role of sports pharmacists in advising athletes or assisting with Therapeutic Use Exemptions at various competition levels, from local fitness enthusiasts to elite Olympic athletes.1 3 9 These contributions remain essential, but they do not capture the breadth of skills that pharmacists can bring to athlete healthcare. Over the past two decades, the scope of pharmacy practice has expanded significantly worldwide, with pharmacists now delivering immunisation programmes, independently prescribing and providing advanced chronic disease management.10,12 Why teams cannot afford to leave out pharmacists Athletes frequently use medications to manage acute injuries, chronic conditions or performance-related concerns. Studies indicate that elite footballers at the 2018 Fédération Internationale de Football Association (FIFA) World Cup averaged nearly one medication per player across a tournament.13 Another study of national-level athletes in Norway reported an average of 1–2 pharmaceuticals per doping control form, with some ranging as high as 15.14 These findings suggest that medication use among athletes is both common and diverse. Given their expertise in medication therapy management, pharmacists are uniquely equipped to ensure safe, effective and evidence-based use of these medications. Sports pharmacists can help bridge gaps in care by offering expertise that complements the care provided by physicians and other healthcare providers. By assuming roles in medication management, patient education and collaborative practice, sports pharmacists not only alleviate some of the burden on physicians but also enhance the quality and accessibility of care. The clinical sports pharmacist in action When structured effectively, sports pharmacy practice models can empower pharmacists to provide direct patient care, optimise medication use and enhance access to care while reducing costs (figure 1). The framework can be adapted for different settings, leveraging tools such as collaborative practice agreements (CPAs), consulting protocols, or defined clinical pathways for care. In the United States (US), a CPA is a formal arrangement between a pharmacist and a prescriber that authorises the pharmacist to provide expanded clinical services under defined protocols.15 A CPA enhances the scope of a sports pharmacist by fostering close collaboration with sports medicine professionals to deliver comprehensive athlete care. Through a CPA, sports pharmacists can initiate, manage and adjust medications tailored to athletes’ evolving needs. By enabling pharmacists to practise at the top of their scope, CPAs strengthen the management of acute or chronic conditions in which medication side effects may affect peak performance.16 The US model of CPAs is fairly unique, but many other countries have developed functionally similar mechanisms that allow pharmacists to expand their scope of practice.17,19 Potential roles and responsibilities of clinical sports pharmacists. Clinical sports pharmacists can have a variety of roles and responsibilities within the interdisciplinary healthcare team, especially when practising with a collaborative practice agreement (CPA) or similar agreement with a supervising physician. Another area in which pharmacists can bring unique skill sets to the team is pharmacogenomics (PGx), which evaluates how an individual’s genetic makeup influences drug metabolism, efficacy and the risk of adverse effects. In athletes, PGx insights can help guide medication selection and dosing.20 For example, sports pharmacists may identify whether a medication should be given at a higher or lower dose depending on how quickly the athlete metabolises it compared with the average person. Leveraging PGx testing allows sports pharmacists to optimise medication therapy, minimise side effects (box 2), improve adherence and enhance outcomes for athletes.21 Pharmacogenomics case example An Olympic-level swimmer receiving escitalopram for generalised anxiety reported persistent fatigue, thermoregulatory intolerance and declining training quality during high-volume swim blocks despite stable dosing and adherence. A sports pharmacist conducted a comprehensive medication, training and recovery review and identified a pattern of adverse effects disproportionate to the prescribed dose. Pharmacogenomic testing was recommended and coordinated in collaboration with the prescribing clinician. Results demonstrated a CYP2C19 poor metaboliser phenotype, associated with elevated escitalopram exposure and increased risk of dose-related adverse effects. Based on genotype findings and training demands, the sports pharmacist collaborated with the prescribing clinician to recommend transitioning to an alternative antidepressant with less reliance on CYP2C19 metabolism. The pharmacist provided counselling on washout considerations, anticipated adjustment periods and symptom monitoring during the medication transition. Following the genotype-guided medication change, the athlete reported improved tolerability and restored training consistency. Sports pharmacists can also order certain laboratory tests, though this ability is dependent on the clinical setting, organisational policies and available resources.19 These examples can include vitamin D for bone integrity, iron studies to assess iron deficiency anaemia and thyroid function for energy metabolism and recovery. Additionally, point-of-care testing and treatment protocols for conditions such as upper respiratory infections enable rapid diagnosis and timely treatment.22 Studies across various outpatient settings have demonstrated that CPAs not only improve patient care outcomes but also achieve high satisfaction among participating healthcare providers.23 Obstacles to integrating sports pharmacists Integrating pharmacists into sports medicine teams faces challenges, including limited awareness of their value and a lack of research linking pharmacist interventions to improved athlete health and performance outcomes and cost savings. Budgetary and institutional funding constraints may limit the expansion of new sports pharmacist roles. Athletic organisations may also be cautious about expanding already large multidisciplinary teams due to risks of miscommunication, potential overlap of responsibilities with sports dietitians in supplement management and athletes’ concerns about confidentiality of sensitive health information. Training opportunities are also limited, with relatively few institutions offering formal sports pharmacy educational programmes. However, new programmes are emerging that provide sports pharmacy-specific continuing education certificates and postgraduate learning opportunities.24 25 While no formal specialty training pathway currently exists, many sports pharmacists pursue focused postgraduate education through recognised certificate programmes, including the University of Southern California Mann Executive Sports Pharmacy Certificate or the International Olympic Committee Diploma of Sports Pharmacy.24 26 Collectively, these developments reflect a growing number of avenues through which pharmacists can acquire the specialised knowledge and competencies required to support the unique needs of athletic populations. A dedicated training pathway is needed to support the integration of sports pharmacy as a specialised field within sports medicine. Despite doctorate-level education and expanding opportunities for specialised training, pharmacists may still encounter hesitation from athletes, coaches, parents and other athlete support personnel regarding their role in athlete care. These concerns may stem from limited familiarity with pharmacists’ clinical training and uncertainty about their scope within sports medicine teams. Addressing these perceptions will require clear delineation of roles and visible interprofessional collaboration. Trust in pharmacists can be effectively fostered when other members of the sports medicine team demonstrate confidence and endorsement of pharmacists’ expertise. The future of multidisciplinary athlete care Interdisciplinary collaboration among sports medicine professionals empowers athletes to make informed, evidence-based decisions, enhancing both health and performance. Despite these potential benefits, barriers do exist that hinder the full integration of pharmacists into sports medicine teams. Creating opportunities for pharmacists to demonstrate their value requires raising awareness of their unique contributions and fostering support among decision-makers. Further research examining the effects of pharmacist interventions on athlete health outcomes, along with cost-benefit analyses to assess the financial implications of this role, can help expand opportunities. A formal definition and certifications for sports pharmacists by governing bodies in the future may further formalise the field. There is growing potential for sports pharmacists to enhance athlete care within multidisciplinary teams. Early evidence and practice models suggest benefits for medication optimisation, improved safety and support for athlete wellness, but further integration will help clarify the pharmacist’s role within sports medicine and athlete care teams.6 Continued collaboration and research will be key to demonstrating the potential value pharmacists can bring to a multidisciplinary team. The views expressed in this material are those of the authors, and do not reflect the official policy or position of Larkin University, Baptist Health, Cedars-Sinai or the Sports Pharmacy Network. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Provenance and peer review: Not commissioned; externally peer reviewed. References